Directory
>
Jeffrey Eisele
Jeffrey Eisele
Chief Development Officer (CDO), Head of Research & Development | Apellis Pharmaceuticals
Basel, Basel-City, Switzerland
Jeffrey Eisele
Summary
Jeffrey Eisele is an accomplished executive in the pharmaceutical industry, currently serving as the Executive Vice President and Chief Development Officer at Apellis Pharmaceuticals. With a strong background in biostatistics and clinical development, he has held various leadership roles across prominent organizations like Novartis and Alcon. Jeffrey's expertise spans clinical trials, regulatory submissions, and the development of innovative therapies in neuroscience and oncology. He has a proven track record of leading cross-functional teams and driving strategic initiatives that enhance product development and market access. His academic foundation in statistics and applied mathematics complements his extensive professional experience, enabling him to make data-driven decisions. Jeffrey's commitment to advancing healthcare through research and development is evident in his contributions to multiple successful product launches. He is passionate about fostering innovation within the industry and mentoring the next generation of leaders.
Jeffrey Eisele
Work Experience
Chief Development Officer (CDO), Head of Research & Development at
Apellis Pharmaceuticals
September 2023 - Present
Chief Development Officer (CDO), Head of Development at
Apellis Pharmaceuticals
January 2023 - Present
Director, Member of the Apellis international GmbH Board of Directors at
Apellis International GmbH
January 2023 - Present
Executive Vice President Program Team Lead at
Apellis Pharmaceuticals
September 2020 - December 2022
Chief Development Officer (CDO), Head of Clinical Development & Regulatory Affairs at
Apellis Pharmaceuticals
January 2022 - December 2022
Vice President, Global Biostatistics Head, Neuroscience and Ophthalmology Development Units at
Novartis
March 2017 - August 2020
Vice President, Global Biostatistics Franchise Head, Ophthalmology at
Novartis
April 2016 - February 2017
Vice President, Head, Cross Divisional IT Projects for Development at
Novartis
December 2015 - March 2016
Vice President, Global Clinical Infometrics (Global Clinical Operations and Biometrics) at
Alcon
January 2009 - November 2015
Vice President, Head of Clinical Development, a.i. at
Alcon
October 2013 - November 2014
Global Head, Neuroscience and Ophthalmics Biostatistics at
Novartis
January 2008 - December 2008
Global Head, Ophthalmics Biostatistics at
Novartis
January 2006 - December 2007
Group Head, Oncology Biostatistics at
Novartis
January 2002 - December 2005
Senior Statistical Methodology Consultant at
Novartis
April 2001 - December 2001
Head (Abteilungsleiter), Global Biometrics Coordination at
Schering Aktiengesellschaft
July 1999 - March 2001
Senior Statistician at
Novartis
July 1993 - June 1999
Jeffrey Eisele
Education
University of Wisconsin-Madison, Post-Doctoral Research Fellow
January 1991 - January 1993
University of Michigan, Doctor Of Philosophy (Ph.D.)
January 1987 - January 1991
University of Michigan, Master Of Arts (M.A.)
January 1986 - January 1987
The George Washington University, Bachelor Of Science (B.S.)
January 1983 - January 1986
Frequently Asked Questions about Jeffrey Eisele
What is Jeffrey Eisele email address?
Jeffrey Eisele's primary email address is **************@apellis.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Jeffrey Eisele work for?
Jeffrey Eisele is a Chief Development Officer (CDO), Head of Research & Development at Apellis Pharmaceuticals, a company specializing in Commercial physical research.
Where Jeffrey Eisele graduated from?
Jeffrey Eisele holds a degree in Biostatistics from University of Wisconsin-Madison.
How can I directly contact Jeffrey Eisele?
To contact Jeffrey Eisele directly, you can use the email address **************@apellis.com. Complete contact information is available upon registration with Muraena.
Who is Jeffrey Eisele?
Jeffrey Eisele is an accomplished executive in the pharmaceutical industry, currently serving as the Executive Vice President and Chief Development Officer at Apellis Pharmaceuticals. With a strong background in biostatistics and clinical development, he has held various leadership roles across prominent organizations like Novartis and Alcon. Jeffrey's expertise spans clinical trials, regulatory submissions, and the development of innovative therapies in neuroscience and oncology. He has a proven track record of leading cross-functional teams and driving strategic initiatives that enhance product development and market access. His academic foundation in statistics and applied mathematics complements his extensive professional experience, enabling him to make data-driven decisions. Jeffrey's commitment to advancing healthcare through research and development is evident in his contributions to multiple successful product launches. He is passionate about fostering innovation within the industry and mentoring the next generation of leaders.
Jeffrey`s contact details
**************@apellis.com
**************@alcon.com
Colleagues
Vice President, Value Access and Policy
VP, Head of Total Rewards
VP, Global Chief Compliance Officer
Co-Founder & Chief Scientific Officer
Vice President, Head of Regulatory Affairs
Vice President, General Manager DACH
Chief Operating Officer
SVP - Technical Operations
Executive Director - Global Commercial Strategy , Ophthalmology
Vice President, Patient Access & Services